Isabl
Isabl is a genomics platform providing a comprehensive cancer test, enabling deeper understanding of a patient's cancer and improved care. Isabl offers complete analysis of the tumor genome and transcriptome, providing valuable insights to guide treatment.
Product Highlights
- Feature 1: Comprehensive genomic test covering 100% of the tumor genome and transcriptome, enabling accurate identification of cancer-associated mutations.
- Feature 2: Isabl provides detailed and actionable insights to help clinicians make informed treatment decisions.
- Feature 3: Isabl contributes to improved cancer treatment outcomes by providing a better understanding of disease characteristics.
Use Cases
- Use case 1: Isabl helps to identify appropriate treatment options for patients based on their tumor genome information.
- Use case 2: Isabl helps to identify patients who may benefit from targeted therapies.
- Use case 3: Isabl helps to predict disease progression and potential outcomes of treatments.
Target Audience
Isabl is targeted towards cancer patients, oncologists, and cancer research centers.
